(Q84028292)
Statements
Interleukin-18 levels on admission are associated with mid-term adverse clinical events in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention (English)
Yan Gao
Guo-xin Tong
Xing-wei Zhang
Jian-hang Leng
Jian-fen Jin
Ning-fu Wang